|
|
|
|
|
by jleyank
116 days ago
|
|
While they weren't a startup, they were a small pharmaceutical company (Novo Nordisk). Yet Ozempic in its various forms totally upended the diet and "comfort food" marketplace. They even distorted the economy of Denmark... They face competition, and need a follow-on, but that's the nature of the pharma biz. Huge, big-loss, big-win field, and if anybody has a drug in any form that addresses Alzheimer's (for example), the profit will be damn near infinite. Europe has all sorts of biotech/pharma. Heard of mRNA drugs? Germany, amongst other sites. |
|